Enhertu 100 mg lyophilized powder for injection Images
Generic Name: fam-trastuzumab deruxtecan
This medication has been identified as Enhertu 100 mg lyophilized powder for injection. It is supplied by Daiichi Sankyo.
Enhertu is used in the treatment of Breast Cancer, Metastatic; Solid Tumors; Non Small Cell Lung Cancer; Breast Cancer; Gastric Cancer and belongs to the drug class HER2 inhibitors. Enhertu 100 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Enhertu
- Generic Name
- fam-trastuzumab deruxtecan
- Strength
- 100 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- HER2 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Daiichi Sankyo
- National Drug Code (NDC)
- 65597-0406
See also:
More about Enhertu (fam-trastuzumab deruxtecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.